ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 123 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 2.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $0 | – | 6 | 0.0% | 0.00% | – |
Q1 2021 | $0 | – | 6 | 0.0% | 0.00% | – |
Q4 2020 | $0 | – | 6 | 0.0% | 0.00% | – |
Q3 2020 | $0 | – | 6 | 0.0% | 0.00% | – |
Q2 2020 | $0 | -100.0% | 6 | -92.4% | 0.00% | – |
Q1 2020 | $4,000 | +33.3% | 79 | +41.1% | 0.00% | – |
Q3 2019 | $3,000 | -40.0% | 56 | 0.0% | 0.00% | – |
Q2 2019 | $5,000 | -50.0% | 56 | -44.0% | 0.00% | – |
Q1 2019 | $10,000 | -69.7% | 100 | -74.2% | 0.00% | – |
Q3 2018 | $33,000 | -84.1% | 387 | -78.5% | 0.00% | -100.0% |
Q2 2018 | $208,000 | +3366.7% | 1,798 | +1698.0% | 0.00% | – |
Q4 2017 | $6,000 | -82.9% | 100 | -87.1% | 0.00% | – |
Q2 2015 | $35,000 | +45.8% | 778 | 0.0% | 0.00% | – |
Q1 2015 | $24,000 | +300.0% | 778 | +380.2% | 0.00% | – |
Q3 2014 | $6,000 | +100.0% | 162 | +161.3% | 0.00% | – |
Q2 2014 | $3,000 | +200.0% | 62 | +181.8% | 0.00% | – |
Q1 2014 | $1,000 | – | 22 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 519,035 | $60,156,000 | 15.36% |
Matarin Capital Management, LLC | 201,703 | $23,377,378,000 | 1.69% |
ARMISTICE CAPITAL, LLC | 124,000 | $14,372,000 | 0.94% |
Sapphire Star Partners LP | 7,803 | $904,000 | 0.93% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 98,631 | $11,431,000 | 0.83% |
FARALLON CAPITAL MANAGEMENT LLC | 1,075,000 | $124,593,000 | 0.77% |
Granahan Investment Management | 100,670 | $11,668,000 | 0.70% |
Virtus ETF Advisers LLC | 6,577 | $762,000 | 0.67% |
AlphaMark Advisors, LLC | 11,115 | $1,288,000 | 0.52% |
Ativo Capital Management LLC | 15,029 | $1,742,000 | 0.48% |